(Q45290293)

11 December 2017

title

A study of molecular changes relating to energy metabolism and cellular stress in people with Huntington's disease: looking for biomarkers (English)

1 reference

Jolanta Krzysztoń-Russjan

11 December 2017

0 references

1 reference

1

object named as

Jolanta Krzysztoń-Russjan

1 reference

11 December 2017

6

Aneta Klimberg

1 reference

11 December 2017

Jerzy T. Marcinkowski

7

object named as

Jerzy T Marcinkowski

1 reference

11 December 2017

Daniel Zielonka

2

1 reference

11 December 2017

Joanna Jackiewicz

3

1 reference

11 December 2017

Sylwia Kuśmirek

4

1 reference

11 December 2017

Irena Bubko

5

1 reference

11 December 2017

Elżbieta L Anuszewska

8

1 reference

11 December 2017

publication date

16 October 2012

1 reference

Journal of Bioenergetics and Biomembranes

11 December 2017

published in

1 reference

11 December 2017

volume

45

1 reference

11 December 2017

issue

1-2

1 reference

11 December 2017

page(s)

71-85

1 reference

Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Polymorphisms in SLC6A4, PAH, GABRB3, and MAOB and modification of psychotic disorder features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

The energetics of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Mechanisms responsible for regulation of branched-chain amino acid catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Myopathy as a first symptom of Huntington's disease in a Marathon runner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Trinucleotide repeats: triggers for genomic disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

PGC-1alpha: a key regulator of energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Validation of plasma branched chain amino acids as biomarkers in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Early alterations of brain cellular energy homeostasis in Huntington disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Huntington's disease: from molecular pathogenesis to clinical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Formation of polyglutamine inclusions in non-CNS tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Safinamide in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Gene expression in Huntington's disease skeletal muscle: a potential biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Suppression of beta cell energy metabolism and insulin release by PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Brain-derived neurotrophic factor in patients with Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9479-3

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

1 reference

12 December 2020

Branched-chain amino acids: enzyme and substrate regulation.

1 reference

12 December 2020

Integrative hypothesis for Huntington's disease: a brief review of experimental evidence.

1 reference

12 December 2020

10.1007/S10863-012-9479-3

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

1038891696

0 references

1 reference